Diagnostic Criteria in Cardiac Sarcoidosis

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

January 1, 2027

Conditions
Cardiac Sarcoidosis
Interventions
DIAGNOSTIC_TEST

ECG, Echo, laboratory tests, CMR, PET-CT, Biopsy

ECG - 12 leads ECG Echo: transthoracic echocardiography laboratory tests: full blood count, electrolytes, creatinine, high sensitive cardiac troponin T, angiontesin converting enzyme, soluble interleukin-2 receptor, cardiac magnetic resonance imaging: 1.5 Tesla scanner, Conventional cine imaging and late gadolinium enhancement imaging PET-CT: 18F-fluorodeoxyglucose (FDG)- positron emission tomograph Biopsy: cardiac biopsy = endomyocardial biopsy, left and right ventricle, at least 5 specimens in formaldehyd and 3 specimens for testing of infectious agents Biopsy: extracardiac biopsy, as accessible according to imaging

Trial Locations (1)

04289

RECRUITING

Heart Center of Leipzig, Leipzig

All Listed Sponsors
lead

Heart Center Leipzig - University Hospital

OTHER